Renal adverse effects following the use of different immune checkpoint inhibitor regimens: A real‐world pharmacoepidemiology study of post‐marketing surveillance data

BACKGROUNDS: Although kidney impairments have been reported following immune checkpoint inhibitors (ICIs) in clinical studies, there are few pharmacoepidemiology studies to compare the occurrences, clinical features, and prognosis of renal adverse effects. METHODS: Disproportionality and Bayesian an...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Gang, Qin, Yan, Fan, Qian‐qian, Zhao, Bin, Mei, Dan, Li, Xue‐mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520336/
https://www.ncbi.nlm.nih.gov/pubmed/32720449
http://dx.doi.org/10.1002/cam4.3198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520336/
https://www.ncbi.nlm.nih.gov/pubmed/32720449
http://dx.doi.org/10.1002/cam4.3198

Ejemplares similares